Giorgi Pkhakadze, MD, MPH, PhD GMJ News Desk Strong Evidence The UK's Medicines and Healthcare Products Regulatory Agency (MHRA) has approved the first oral glucagon-like peptide-1 (GLP-1) receptor agonist pill for weight loss, marking a significant advancement in obesity treatment accessibility
Levines practice for a more complete outcome
If you always struggle with Friday injections during summer travel season, maybe Tuesday is a better permanent choice year-round
Severity ranges from mild queasiness to more significant stomach upset, though severe nausea is uncommon
1), the study population was divided as follows: the GLP-1RA cohort consisted of patients prescribed initial GLP-1RAs between April 2013 and April 2019 who were never prescribed SGLT2 inhibitors before the initial GLP-1RAs prescription, and the SGLT2 cohort consisted of patients prescribed initial SGLT2 inhibitors between April 2013 and April 2019 who were never prescribed GLP-1RAs before the initial SGLT2 prescription